2021-01-06,Clearside Biomedical Announces Pricing of $12 Million Registered Direct Offering
2020-11-27,"Here is What Hedge Funds Think About Clearside Biomedical, Inc. (CLSD)"
2020-11-16,Clearside Biomedical Announces Data Presentations at the American Academy Ophthalmology (AAO) 2020 Annual Meeting and Publication on the Suprachoroidal Injection Procedure in Translational Vision Science and Technology
2020-11-11,Clearside Biomedical to Present at the Stifel 2020 Virtual Healthcare Conference
2020-11-10,Clearside Biomedical Announces Third Quarter 2020 Financial Results and Provides Corporate Update
2020-11-10,"Clearside Biomedical, Inc. to Host Earnings Call"
2020-10-30,"Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Tuesday, November 10, 2020"
2020-10-27,Clearside Biomedical (CLSD) Enters Oversold Territory
2020-09-23,Clearside Biomedical Announces Clinical Data Presentations at The Retina Society 2020 and Publication of XIPERE Data in Diabetic Macular Edema in Ophthalmology Retina
2020-09-11,Clearside Biomedicals Oncology Licensing Partner Doses First Patient in its Phase 2 Study in Patients with Choroidal Melanoma Using SCS Microinjector® for Suprachoroidal Delivery
2020-09-09,Clearside Biomedical to Present at the Virtual H.C. Wainwright 22nd Annual Global Investment Conference
2020-09-09,Clearside Biomedicals Licensing Partner Doses First Patient in its Phase 2 Gene Therapy Trial Using SCS Microinjector® for Suprachoroidal Delivery
2020-09-02,"Have Insiders Been Buying Clearside Biomedical, Inc. (NASDAQ:CLSD) Shares?"
2020-08-26,Clearside Biomedical Expands Patent Portfolio in the U.S. and Europe
2020-08-10,"Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue Estimates"
2020-08-10,Clearside Biomedical Announces Second Quarter 2020 Financial Results and Provides Corporate Update
2020-08-10,Clearside Biomedical Announces U.S. FDA Acceptance of Investigational New Drug Application for CLS-AX (axitinib injectable suspension) Administered in Suprachoroidal Space
2020-08-04,Clearside Biomedical to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
2020-08-03,"Clearside Biomedical, Inc. (CLSD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release"
2020-07-30,"Clearside Biomedical to Report Second Quarter 2020 Financial Results and Provide Corporate Update on Monday, August 10, 2020"
2020-07-29,"Clearside Biomedical, Inc. (CLSD) May Report Negative Earnings: Know the Trend Ahead of Q2 Release"
2020-07-27,Clearside Biomedical Announces Multiple Presentations at the ASRS 2020 Virtual Annual Meeting
2020-06-22,"Clearside Biomedical, Inc. (CLSD) Upgraded to Buy: Here's What You Should Know"
2020-06-17,Clearside Biomedical Announces Numerous Presentations at the ARVO 2020 Meeting
2020-06-04,"Hedge Funds Warming Up To Clearside Biomedical, Inc. (CLSD) Again?"
2020-06-04,3 Strong Buy Penny Stocks That Could See Outsized Returns
2020-05-08,"Clearside Biomedical Inc (CLSD) Reports Q1 Loss, Tops Revenue Estimates"
2020-05-08,Clearside Biomedical Announces First Quarter 2020 Financial Results
2020-05-06,"Will Clearside Biomedical, Inc.(CLSD) Report Negative Q1 Earnings? What You Should Know"
2020-04-28,Clearside Biomedical Revises NDA Resubmission Timeline and XIPERE Commercial Partnership with Bausch Health
2020-04-22,"Clearside Biomedical Appoints Nancy J. Hutson, Ph.D. to its Board of Directors"
2020-04-09,Clearside Biomedical Establishes Scientific Advisory Board with Distinguished Retinal Physicians
2020-04-08,Clearside Biomedical to Present at the Needham Virtual Healthcare Conference
2020-03-30,Edited Transcript of CLSD earnings conference call or presentation 11-Mar-20 8:30pm GMT
2020-03-11,"Clearside Biomedical, Inc. (CLSD) Reports Q4 Loss, Lags Revenue Estimates"
2020-03-11,Clearside Biomedical Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
2020-03-11,Clearside Biomedical Appoints Dr. George Lasezkay as President and Chief Executive Officer
2020-03-11,Clearside Biomedical Announces License Agreement with Arctic Vision for XIPERE (triamcinolone acetonide suprachoroidal injectable suspension) in Greater China and South Korea
2020-03-11,"Clearside Biomedical, Inc. to Host Earnings Call"
2020-03-04,"Clearside Biomedical, Inc. (CLSD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?"
2020-02-27,"Clearside Biomedical to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update on Wednesday, March 11, 2020"
2020-02-26,Clearside Biomedical to Present at Two Upcoming Investor Conferences in March 2020
2020-02-25,Clearside Biomedical Pipeline Highlighted in Oral Presentations at the Annual Angiogenesis and Macula Society Meetings
2020-02-05,Clearside Biomedical Announces Presentations to be Given at Angiogenesis and Macula Society Conferences
2020-01-28,"Bausch Health, Clearside Biomedical publish data on eye drug"
2020-01-28,Bausch Health and Clearside Biomedical Announce Publication of PIVOTAL Phase 3 Data ON XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) in Ophthalmology
2020-01-20,Will Clearside Biomedical Continue to Surge Higher?
2020-01-06,Clearside Biomedical to Present at the 38th Annual J.P. Morgan Healthcare Conference
2019-12-31,"Calculating The Intrinsic Value Of Clearside Biomedical, Inc. (NASDAQ:CLSD)"
2019-12-24,Biotech Leading in Q4: Best ETFs &amp; Stocks
2019-12-18,Is the Options Market Predicting a Spike in Clearside Biomedical (CLSD) Stock?
2019-11-29,"These 3 Biotech Stocks Could More Than Double in 2020, Says Wedbush"
2019-11-22,Edited Transcript of CLSD earnings conference call or presentation 6-Nov-19 9:30pm GMT
2019-11-13,Clearside Biomedical to Present at the Stifel 2019 Healthcare Conference
2019-11-06,"Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Tops Revenue Estimates"
2019-11-06,Clearside Biomedical Announces Third Quarter 2019 Financial Results and Provides Corporate Update
2019-10-30,"Clearside Biomedical to Report Third Quarter 2019 Financial Results and Provide Corporate Update on Wednesday, November 6, 2019"
2019-10-30,Clearside Biomedical Announces Option Exercise by REGENXBIO for Global License for Use of SCS Microinjector in AAV Gene Therapy Delivery
2019-10-23,"The Daily Biotech Pulse: Eli Lily Revenues Trail Estimates, Moderna Gets Fast Track Designation, MacroGenics' Lukewarm Breast Cancer Data"
2019-10-23,"Bausch Health Licenses Clearside Biomedical's XIPERE (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis"
2019-10-17,Clearside Biomedical Suprachoroidal Injection Platform Featured in Multiple Presentations at the American Academy of Ophthalmology (AAO) 2019 Annual Meeting
2019-10-13,"The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings"
2019-10-03,Clearside Biomedical Announces Multiple Presentations to be Given at the American Academy of Ophthalmology (AAO) 2019 Annual Meeting
2019-09-19,Clearside Biomedical Featured at Multiple European Scientific Retinal Congresses
2019-09-17,Those Who Purchased Clearside Biomedical (NASDAQ:CLSD) Shares Three Years Ago Have A 93% Loss To Show For It
2019-09-09,Edited Transcript of CLSD earnings conference call or presentation 7-Aug-19 8:30pm GMT
2019-09-09,This Rockville biotech has added another deal to its growth plan
2019-09-04,REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314
2019-09-03,Clearside Biomedical to Present at the Janney Montgomery Scott Healthcare Conference
2019-08-28,"Biotech Stock Roundup: AMGN to Buy CELG's Otezla, ALXN's Soliris Gets EC Nod &amp; More"
2019-08-22,Clearside Biomedical Provides New Drug Application Update for XIPERE (triamcinolone acetonide suprachoroidal injectable suspension)
2019-08-07,"Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Misses Revenue Estimates"
2019-08-07,Clearside Biomedical Announces Second Quarter 2019 Financial Results and Provides Corporate Update
2019-08-06,Clearside Biomedical to Present at the 2019 Wedbush PacGrow Healthcare Conference
2019-07-31,"Clearside Biomedical to Report Second Quarter 2019 Financial Results and Provide Corporate Update on Wednesday, August 7, 2019"
2019-07-31,Clearside Biomedical Announces Multiple Oral Presentations Delivered at the American Society of Retinal Specialists (ASRS) Annual Meeting
2019-07-18,Clearside Biomedical Announces Multiple Oral Presentations to be Given at the American Society of Retinal Specialists (ASRS) Annual Meeting
2019-07-09,Clearside Biomedical Announces License Agreement with Aura Biosciences for Suprachoroidal Space Microinjector Designed to Optimize Ocular Oncology Drug Delivery
2019-06-19,"Is Clearside Biomedical, Inc.'s (NASDAQ:CLSD) Balance Sheet A Threat To Its Future?"
2019-06-11,Clearside Biomedical to Present at the JMP Securities Life Sciences Conference
2019-05-15,Edited Transcript of CLSD earnings conference call or presentation 8-May-19 12:30pm GMT
2019-05-15,Clearside Biomedical to Present at the UBS Global Healthcare Conference
2019-05-08,Clearside Biomedical Announces First Quarter 2019 Financial Results and Provides Corporate Update
2019-05-01,Clearside Biomedicals Suprachoroidal Space Injection Platform Featured at Multiple Ophthalmology and Gene Therapy Medical Meetings
2019-04-25,"Clearside Biomedical to Report First Quarter 2019 Financial Results and Provide Corporate Update on Wednesday, May 8, 2019"
2019-04-18,Clearside Biomedical Announces Multiple Presentations on its Suprachoroidal Space® Injection Platform at Upcoming Medical Meetings
2019-04-08,Clearside Biomedical Appoints Dr. George Lasezkay as Interim CEO
2019-04-02,Clearside Biomedical to Present at the 18th Annual Needham Healthcare Conference
2019-03-18,Edited Transcript of CLSD earnings conference call or presentation 12-Mar-19 9:00pm GMT
2019-03-12,Clearside Biomedical Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
2019-03-04,Clearside Biomedical to Present at the Cowen and Company 39th Annual Health Care Conference
2019-02-27,"Clearside Biomedical to Report 2018 Financial Results and Provide Corporate Update on Tuesday, March 12, 2019"
2019-02-25,"Do Insiders Own Shares In Clearside Biomedical, Inc. (NASDAQ:CLSD)?"
2019-02-20,Four Tech Stocks Bubbling with Excitement
2019-02-20,"Recent Analysis Shows Cisco, Zendesk, Clearside Biomedical, Conn's, NIC, and Commercial Vehicle Group Market Influences  Renewed Outlook, Key Drivers of Growth"
2019-02-20,"Clearside Biomedical Receives Notification of FDA Acceptance of NDA Filing for XIPERE (triamcinolone acetonide ophthalmic suspension) for Suprachoroidal Injection with PDUFA Date Set for October 19, 2019"
2019-02-19,Clearside Biomedicals Suprachoroidal Injection Platform Featured in Multiple Oral Presentations at 42nd Annual Meeting of The Macula Society
2019-02-15,Healthcare Companies Positioned in Major Markets
2019-01-20,Presentation of Clearside Biomedicals Extension Study of PEACHTREE for XIPERE Exhibits Durability Following Second Dose
2019-01-02,Clearside Biomedical to Present at the 37th Annual J.P. Morgan Healthcare Conference
